Hepatocellular Carcinoma: Successes with Regorafenib in Second-line Therapy

被引：0

|

作者：

Weiss, Johannes

机构：

来源：

ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2017年 / 55卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[1] Regorafenib as second-line therapy in hepatocellular carcinoma
Duffy, Austin G.
Greten, Tim F.
[J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (03) : 141 - 142
[2] Regorafenib as second-line therapy in hepatocellular carcinoma
Austin G. Duffy
Tim F. Greten
[J]. Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 141 - 142
[3] Regorafenib promising second-line treatment in hepatocellular carcinoma
不详
[J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (08) : 446 - 446
[4] Cost Effectiveness of Regorafenib as Second-Line Therapy for Patients With Advanced Hepatocellular Carcinoma
Parikh, Neehar D.
Singal, Amit G.
Hutton, David W.
[J]. CANCER, 2017, 123 (19) : 3725 - 3731
[5] Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Trojan, Joerg
Waidmann, Oliver
[J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2016, 3 : 31 - 36
[6] COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB AS A SECOND-LINE THERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN CHINA
Xiao, D.
Zhu, S.
Sun, W.
Xuan, J.
[J]. VALUE IN HEALTH, 2019, 22 : S187 - S188
[7] Second-Line Therapy for Patients With Hepatocellular Carcinoma
Frenette, Catherine T.
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 3 - 5
[8] A study of cadonilimab combined with regorafenib as second-line or later therapy in patients with advanced hepatocellular carcinoma (aHCC)
Qi, Qi
Liu, Yang
Li, Rentao
Liu, Yayue
Zhang, Xihao
Lu, Wei
Li, Huikai
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[9] Regorafenib and the RESORCE trial: a new second-line option for hepatocellular carcinoma patients
Bruix, Jordi
[J]. HEPATIC ONCOLOGY, 2016, 3 (03) : 187 - 189
[10] Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma
Kudo, M.
[J]. LIVER CANCER, 2016, 5 (04) : 235 - 244

← 1 2 3 4 5 →